Aktiesnakken — Januar 2012
-
nope
-
nu begyndte jeg jo at lede efter fejl, og fandt endnu en
- samlet værdi inde på porteføljen viser 262.390, mens den i oversigten og også i ranking viser 260.150 -
Dendreon attributed the boost to improved insurance reimbursement for the product, noting that the average reimbursement period for prescribing physicians had dropped to less than 30 days.
-
-
@aspek det er fordi den er forsinket kursen.
-
den stiger til 42 men sigter mod 38? Var det ikke omvendt igår?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind